MAPT and Alzheimer disease: This raises the intriguing possibility that pathological phosphorylated tau could affect myosin/NMII structure and/or function, causing pathological neuronal cytoskeletal abnormalities in AD, such as dystrophic neurites, and axonal and synapse degeneration.